InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
33%
T+90 mean return
-24.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Balo Andrew K, Directeur Médical. Insider active across 2 companies, notably DEXCOM INC. In total, 14 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €1m. History available since 3 June 2021. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
75 shares0Common Stock, par value $0.001 per shareSEC:0001323190-25-000003:0
3,332 shares0Common Stock, par value $0.001 per shareSEC:0001323190-25-000003:1
1,285 shares0Common Stock, par value $0.001 per shareSEC:0001323190-25-000003:2
4,490 shares0Common Stock, par value $0.001 per shareSEC:0001474506-25-000067:0
3,275 shares@ US$111.39925.5% of flowCommon StockSEC:0001093557-23-000075:0
4,984 shares@ US$0.0010.0000% mcap0.0% of flowCommon StockSEC:0001093557-22-000045:0
2,498 shares0Common StockSEC:0001093557-21-000223:0
2,498 shares0Common StockSEC:0001093557-21-000223
683 shares@ US$512.18720.0012% mcap29.2% of flowCommon StockSEC:0001093557-21-000195:0
683 shares@ US$512.187221.8% of flowCommon StockSEC:0001093557-21-000195
578 shares@ US$428.505615.5% of flowCommon StockSEC:0001093557-21-000177
578 shares@ US$428.50560.0008% mcap20.8% of flowCommon StockSEC:0001093557-21-000177:0
18,774 shares0Common StockSEC:0001093557-21-000164:0
18,774 shares0Common StockSEC:0001093557-21-000164
14 of 14 declarations
About Balo Andrew K
Andrew K. Balo is Executive Vice President, Global Medical Affairs at Dexcom Inc. In this role, he oversees the company's medical and strategic initiatives. His expertise in the medical field is essential for the development of Dexcom.
